Ultradian Diagnostics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Ultradian Diagnostics General Information

Description

Operator of a medical device company intended to develop medical bio-sensors to track vitals. The company leverages technology to develop bio-sensors that transmit physiological information to a visual monitor for managing chronic diseases, enabling healthcare professionals to track, manage, and access chronic ailments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Monitoring Equipment
Corporate Office
  • 22 Bruen Court
  • Suite D202
  • Rensselaer, NY 12144
  • United States
+1 (518) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ultradian Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000 Completed Generating Revenue
5. Angel (individual) 000 000 Completed Generating Revenue
4. Grant 12-Sep-2013 00.000 Completed Generating Revenue
3. Grant 01-Jan-2010 00000 Completed Startup
2. Angel (individual) 02-Mar-2009 Completed Startup
1. Accelerator/Incubator 01-Jan-2005 Completed Startup
To view Ultradian Diagnostics’s complete valuation and funding history, request access »

Ultradian Diagnostics Patents

Ultradian Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3311150-A1 Methods and devices for determining metabolic states Inactive 18-Jun-2015 0000000000
US-20180160985-A1 Methods and devices for determining metabolic states Inactive 18-Jun-2015 0000000000 0
US-20100213079-A1 Microsecond response electrochemical sensors and methods thereof Inactive 24-Feb-2009 00000000000 00
EP-2416893-B1 Microsecond response electrochemical sensors and methods thereof Inactive 24-Feb-2009 00000000000
EP-2416893-A4 Microsecond response electrochemical sensors and methods thereof Active 24-Feb-2009 G01N33/5438
To view Ultradian Diagnostics’s complete patent history, request access »

Ultradian Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Gib Conover Chief Operating Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Ultradian Diagnostics Board Members (3)

Name Representing Role Since
Douglas Pickard Self Board Member 000 0000
Robert Blackman Self Board Member 000 0000
William Cromie MD Self Board Member 000 0000
To view Ultradian Diagnostics’s complete board members history, request access »

Ultradian Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ultradian Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
To view Ultradian Diagnostics’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »